Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other financing activities (2017 - 2025)

Cogent Biosciences' Other financing activities history spans 6 years, with the latest figure at $46.6 million for Q4 2025.

  • Quarterly Other financing activities changed N/A to $46.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $48.9 million for FY2025, N/A changed from the prior year.
  • Other financing activities came in at $46.6 million for Q4 2025, up from $235000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $46.6 million in Q4 2025 to a low of $235000.0 in Q3 2025.
  • The 4-year median for Other financing activities is $10.7 million (2023), against an average of $11.7 million.
  • Year-over-year, Other financing activities decreased 0.93% in 2023 and then plummeted 93.97% in 2025.
  • Cogent Biosciences' Other financing activities stood at $10.8 million in 2022, then dropped by 0.93% to $10.7 million in 2023, then increased by 8.41% to $11.6 million in 2024, then surged by 301.66% to $46.6 million in 2025.
  • Per Business Quant, the three most recent readings for COGT's Other financing activities are $46.6 million (Q4 2025), $235000.0 (Q3 2025), and $1.4 million (Q2 2025).